Dr. Eileen M. O'Reilly, a pancreatic cancer expert at Memorial Sloan-Kettering Cancer Center in New York, says there are six or seven known genetic factors involved in pancreatic cancer, including the BRCA1 and BRCA2 mutations more commonly associated with an increased risk of cancers of the breast, ovary, colon and prostate.
The reason that deletions have been identified more frequently in forward genetic screens than in our reverse genetic screen is probably because these mutations are much more likely to produce a phenotype than the single bp mutations more commonly produced by EMS.
SDHB mutation more commonly results in the formation of paragangliomas associated with the sympathetic system [20, 21].
In addition, the distribution of VWS/PPS mutations in the DNA-binding domain was skewed with residues that were predicted to contact DNA being mutated more commonly.
These results, together with previously reported studies, indicate that germline mutations and, more commonly, somatic mutations in E-cadherin may have an influence on the behaviour of the tumours, rather than predispose to breast cancer.
It has been hypothesized that VWS is caused primarily by loss-of-function mutations and PPS is caused by dominant negative mutations because mutations affecting DNA binding (i.e., R84C, R84H) are highly associated with PPS, whereas truncation mutations are more commonly found in VWS.
Investigation of the haplotypes on which frequent PARK2 mutations reside, showed that most CNVs are independent events, whereas point mutations were more commonly transmitted from common founders [ Periquet et al., 2001].
SPINK1 mutations were more commonly associated with Chinese children with ICP.
BRAF mutations are more commonly seen in melanomas arising in intermittently sun-exposed sites, implying that UV light (as described earlier) may be one such stimulus.
While EGFR mutations are more commonly observed in patients with these clinical characteristics (i.e., Asian ethnicity, adenocarcinoma histology, etc)., they can occur in patients who do not fit these characteristics as well.
Furthermore, the activating EGFR mutations are more commonly observed in patients with non-squamous cell carcinoma and no prior history of smoking, as well as in females and those of Asian descent [ 46].
